Statements 16 Apr 2025 Statement from the Drugs for Neglected Diseases initiative (DNDi) on the conclusion of WHO Pandemic Agreement negotiations
Press releases 15 Apr 2025 New treatment for cryptococcal meningitis enters Phase II trial as global HIV funding cuts threaten to cause a massive increase in advanced HIV disease
Stories 14 Apr 2025 DNDi supporting a pioneering project that integrates Indigenous knowledge in the treatment of Chagas
In the media 3 Apr 2024 Comme la Guinée avec la maladie du sommeil, 44 pays ont réussi à éradiquer des pathologies depuis cinq ans Le Monde
Viewpoints 3 Apr 2025 Africa’s greatest health challenges won’t be solved without female scientists TRT Afrika
Scientific articles 31 Mar 2025 Discovery and early optimization of 1H-indole-2-carboxamides with anti-Trypanosoma cruzi activity Journal of Medicinal Chemistry
Scientific articles 30 Aug 2024 The case for a global therapeutics development coalition: Building a therapeutics pipeline for pandemic and endemic diseases PLOS Global Public Health
Scientific articles 21 Aug 2024 Disease-specific differences in pharmacokinetics of paromomycin and miltefosine between post-kala-azar dermal leishmaniasis and visceral leishmaniasis patients in Eastern Africa The Journal of Infectious Diseases
Scientific articles 15 Aug 2024 Paving the way for affordable and equitable liposomal amphotericin B access worldwide The Lancet Global Health
Scientific articles 15 Aug 2024 A guide for the generation of repositories of clinical samples for research on Chagas disease PLOS Neglected Tropical Diseases
Scientific articles 15 Aug 2024 A standardized clinical database for research in Chagas disease: The NHEPACHA network PLOS Neglected Tropical Diseases
Scientific articles 8 Aug 2024 The long and winding road towards new treatments against lymphatic filariasis and onchocerciasis Trends in Parasitology
Scientific articles 5 Aug 2024 How do we classify organ involvement in Chagas disease? A systematic review of organ involvement since 1909, highlighting the urgent need for a universal classification system in chronic Chagas disease PLOS Neglected Tropical Diseases
Scientific articles 1 Aug 2024 Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial Lancet Infectious Diseases
Scientific articles 15 Jul 2024 Differences in the cellular immune response during and after treatment of Sudanese patients with post-kala-azar dermal leishmaniasis, and possible implications for outcome Journal of Epidemiology and Global Health
Scientific articles 15 Jul 2024 Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements Wellcome Open Research
Scientific articles 2 Jul 2024 Design, conduct, analysis, and reporting of therapeutic efficacy studies in visceral leishmaniasis: A systematic review of published reports, 2000–2021 American Journal of Tropical Medicine and Hygiene
Scientific articles 20 Jun 2024 A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh PLOS Neglected Tropical Diseases
Scientific articles 31 May 2024 Demystifying in vivo bioluminescence imaging of a Chagas disease mouse model for drug efficacy studies Journal of Visualized Experiments
Scientific articles 21 May 2024 Modular and divergent synthesis of 2,N3-disubstituted 4-quinazolinones facilitated by regioselective N-alkylation Organic and Biomolecular Chemistry
Scientific articles 20 May 2024 Population pharmacokinetics of ravidasvir in adults with chronic hepatitis C virus infection and impact of antiretroviral treatment Antimicrobial Agents and Chemotherapy
Scientific articles 16 May 2024 Chagas disease in the United States: a call for increased investment and collaborative research The Lancet Regional Health – Americas
